FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Legacy Pharmaceutical Packaging ATENOLOL Tablets Recall

ATENOLOL Tablets, USP, 50 mg, 30-count bottle, Rx only, Distributed by: The Kroger Co

Legacy Pharmaceutical Packaging LLC · Earth City, MO

Risk level
Class II
Reported by FDA
Mar 29, 2017
Recall ID
D-0606-2017
Check your lot numberHow we source this data

Summary

Legacy Pharmaceutical Packaging recalled ATENOLOL Tablets starting Mar 7, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0606-2017 on Mar 29, 2017. Reason: Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Product description

ATENOLOL Tablets, USP, 50 mg, 30-count bottle, Rx only, Distributed by: The Kroger Co., 1014 Vine Street, Cincinnati, OH 45202; Manufactured for: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045; NDC 68645-493-54.

Lot numbers, UPCs & expiration codes

Lot # 161901, Exp 04/18

Where it was sold

Product was shipped to distribution centers in TN, IN, and AZ then further shipped the product to retail pharmacies nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0606-2017
Classification
Class II
Status
Terminated
Recall initiated
Mar 7, 2017
FDA report date
Mar 29, 2017
Quantity
48,012 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Legacy Pharmaceutical Packaging LLC

Original FDA data

Every field from FDA enforcement report D-0606-2017, exactly as published.

Show all FDA fields
City
Earth City
State
MO
Status
Terminated
Country
United States
Event ID
76666
Address
13333 Lakefront Dr
Code information
Lot # 161901, Exp 04/18
Postal code
63045-1514
Report date
Mar 29, 2017
Product type
Drugs
Recall number
D-0606-2017
Classification
Class II
Recalling firm
Legacy Pharmaceutical Packaging LLC
Product quantity
48,012 bottles
Termination date
Aug 23, 2019
Reason for recall
Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
ATENOLOL Tablets, USP, 50 mg, 30-count bottle, Rx only, Distributed by: The Kroger Co., 1014 Vine Street, Cincinnati, OH 45202; Manufactured for: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045; NDC 68645-493-54.
Distribution pattern
Product was shipped to distribution centers in TN, IN, and AZ then further shipped the product to retail pharmacies nationwide in the USA.
Recall initiation date
Mar 7, 2017
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Mar 21, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0606-2017, published Mar 29, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls